Biodesix, Inc.

NASDAQ:BDSX

1.37 (USD) • At close November 8, 2024
Bedrijfsnaam Biodesix, Inc.
Symbool BDSX
Munteenheid USD
Prijs 1.37
Beurswaarde 199,289,790
Dividendpercentage 0%
52-weken bereik 1.15 - 2.21
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Scott Hutton
Website https://www.biodesix.com

An error occurred while fetching data.

Over Biodesix, Inc.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the

Vergelijkbare Aandelen

Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc.

PLSE

19.87 USD

Unity Biotechnology, Inc. logo

Unity Biotechnology, Inc.

UBX

1.17 USD

89bio, Inc. logo

89bio, Inc.

ETNB

10.45 USD

Purple Biotech Ltd. logo

Purple Biotech Ltd.

PPBT

2.81 USD

Cryo-Cell International, Inc. logo

Cryo-Cell International, Inc.

CCEL

8.734 USD

Biotricity, Inc. logo

Biotricity, Inc.

BTCY

0.34 USD

Molecular Templates, Inc. logo

Molecular Templates, Inc.

MTEM

0.358 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)